Clinical Trial Update: Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy

View source ↗

Summary

A clinical trial update describes a multimodal PET imaging approach using 18F-FDG, SV2A-targeted radiotracers, and TSPO ligands to aid resection planning in dru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)
• SV2A PET radiotracer (SV2A PET ligand)
• TSPO PET radiotracer (TSPO ligand)

Snippet

Sponsor: Weibing Miao, PhD | Conditions: Epilepsy, PET / MR | Status: NOT_YET_RECRUITING